Previous studies have shown that NTSR1 is highly expressed in tumor tissues compared with normal tissues and that its expression correlates with a poor prognosis in various kinds of tumors, including glioma, small cell lung carcinoma, endometrial carcinoma, and breast cancer [28, 29, 30, 31, 32]. This evidence concerns the gene NTSR1 and glioma.